Yonghui Supermarket: There are no major matters that should be disclosed but not disclosed.Shan Ying International: It is proposed to raise the share repurchase price ceiling to 3 yuan/share. Shan Ying International (600567) announced on the evening of December 12 that it intends to adjust the share repurchase price ceiling from 2.34 yuan/share to 3 yuan/share.World Gold Council: The price of gold is expected to hit its best annual performance in more than 10 years. It is expected that there will be a positive but moderate growth next year. According to the report of the World Gold Council, the price of gold is expected to hit its best annual performance in more than 10 years, with an increase of 28% as of November. Behind this, the purchases of the central bank and investors offset the significant slowdown in consumer demand. Looking ahead, all eyes are focused on the impact of Trump's second term on the global economy. The current forecast of GDP, yield and inflation shows that gold will have a positive but much more moderate growth in 2025. The upward trend may benefit from a sharp drop in interest rates, an increase in volatility, or the continuous higher-than-average demand for gold by the central bank. On the contrary, higher long-term interest rates or weak demand for gold consumption may bring headwinds.
Huichuan Technology traded 2.46 million shares today, with a turnover of 151 million yuan. Huichuan Technology traded 2.46 million shares today, with a turnover of 151 million yuan, accounting for 10.48% of the total turnover of the day. The transaction price was 61.25 yuan, which was the same as the market closing price of 61.25 yuan.Dong Yuhui has recently established three new companies. According to Tianyancha App, Zisan Province (Beijing) Technology Co., Ltd. was recently established, with the legal representative of Dong Yuhui and the registered capital of 10 million RMB. Its business scope includes Internet information services, value-added telecommunications services of the first kind, network culture management, film screening, alcohol management, radio and television program production and management, etc. According to the shareholder information, the company is jointly held by Zhongnan Yuantiao (Xi 'an) Technology Co., Ltd., Dong Yuhui and Long song Youhe (Beijing) Technology Partnership (Limited Partnership). It is worth mentioning that Zhongnan Yuantiao (Xi 'an) Technology Co., Ltd. and Long song Youhe (Beijing) Technology Partnership (Limited Partnership) were established recently with registered capital of 10 million RMB and 1 million RMB respectively.Market News: A fire broke out at Kaliningrad Shipyard in Russia.
Lu 'an Huaneng: The raw coal output in November was 5.09 million tons, down 5.39% year-on-year. Lu 'an Huaneng announced that the raw coal output in November 2024 was 5.09 million tons, down 5.39% year-on-year; The sales volume of commercial coal was 5.36 million tons, up 18.32% year-on-year. In 2024, the cumulative output of raw coal was 52.25 million tons, down 4.88% year-on-year; The cumulative sales volume of commercial coal was 47.09 million tons, down 4.48% year-on-year.The US dollar just hit the 7.2700 yuan mark against the offshore RMB, and the latest price was 7.2700 yuan, down 0.10% in the day. The US dollar against the onshore RMB was recently reported at 7.2660 yuan, up 0.06% in the day.The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14